Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

PARPi as the Emerging Treatment Strategy in BRCA+ Metastatic TNBC: Improvement in PFS in Platinum Naive /Sensitive Disease

63 views
December 4, 2019
Comments 0
Login to view comments. Click here to Login